Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Carmen M. Stanca, Jawad Babar, Vineet Singal, Esra Ozdenerol & Joseph A. Odin. (2008) Pathogenic Role of Environmental Toxins in Immune-Mediated Liver Diseases. Journal of Immunotoxicology 5:1, pages 59-68.
Read now
Read now
Articles from other publishers (34)
Aalam Sohal, Sanya Kayani & Kris V. Kowdley. (2024) Primary Sclerosing Cholangitis. Clinics in Liver Disease 28:1, pages 129-141.
Crossref
Crossref
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm & Michael Trauner. (2022) EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 77:3, pages 761-806.
Crossref
Crossref
Lisa Schulz, Marcial Sebode, Sören A. Weidemann & Ansgar W. Lohse. (2018) Variant syndromes of primary biliary cholangitis. Best Practice & Research Clinical Gastroenterology 34-35, pages 55-61.
Crossref
Crossref
Albert J. Czaja. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis
41
57
.
Suzanne M. Selvaggi. (2016) Bile duct brushing cytology: Cytohistologic/fine-needle aspiration correlation and diagnostic pitfalls. Journal of the American Society of Cytopathology 5:5, pages 296-300.
Crossref
Crossref
. 2013. Principles and Practice of Phytotherapy. Principles and Practice of Phytotherapy
183
350
.
Brita Ardesjö Lundgren, Fredrik Rorsman, Guida M. Portela-Gomes, Lars Grimelius, Kristina Nilsson Ekdahl, Bo Nilsson & Olov Ekwall. (2010) Identification of complement C3 as an autoantigen in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 22:4, pages 429-436.
Crossref
Crossref
Randeep Kashyap, Parvez Mantry, Rajeev Sharma, Manoj K. Maloo, Saman Safadjou, Yanjie Qi, Ashok Jain, Benedict Maliakkal, Charlotte Ryan & Mark Orloff. (2009) Comparative Analysis of Outcomes in Living and Deceased Donor Liver Transplants for Primary Sclerosing Cholangitis. Journal of Gastrointestinal Surgery 13:8, pages 1480-1486.
Crossref
Crossref
Nissa I. Erickson & William F. Balistreri. 2009. Liver Disease in Children. Liver Disease in Children
459
477
.
T. H. Karlsen, K. M. Boberg & E. Schrumpf. 2007. Bile Acids: Biological Actions and Clinical Relevance. Bile Acids: Biological Actions and Clinical Relevance
226
237
.
T. R. Orchard. 2006. Colitis: Diagnosis and Therapeutic Strategies. Colitis: Diagnosis and Therapeutic Strategies
70
76
.
Yoshihiro Numata, Susuma Tazuma, Yoshitaka Ueno, Tomoji Nishioka, Hideyuki Hyogo & Kazuaki Chayama. (2005) Therapeutic Effect of Repeated Natural Killer T Cell Stimulation in Mouse Cholangitis Complicated by Colitis. Digestive Diseases and Sciences 50:10, pages 1844-1851.
Crossref
Crossref
Lester J. Layfield & Harvey Cramer. (2005) Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: Report of two cases.. Diagnostic Cytopathology 32:2, pages 119-124.
Crossref
Crossref
Paola G. Blanco, Munir M. Zaman, Omer Junaidi, Sunil Sheth, Rhonda K. Yantiss, Imad A. Nasser & Steven D. Freedman. (2004)
Induction of colitis in
cftr
−/−
mice results in bile duct injury
. American Journal of Physiology-Gastrointestinal and Liver Physiology 287:2, pages G491-G496.
Crossref
Crossref
YOSHIHIRO NUMATA, SUSUMU TAZUMA, TOMOJI NISHIOKA, YOSHITAKA UENO & KAZUAKI CHAYAMA. (2004) Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium. Journal of Gastroenterology and Hepatology 19:8, pages 910-915.
Crossref
Crossref
Kristine Wiencke, Andrew Sverre Louka, Anne Spurkland, Morten Vatn, the IBSEN study group, Erik Schrumpf & Kirsten Muri Boberg. (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. Journal of Hepatology 41:2, pages 209-214.
Crossref
Crossref
Xiao-Song He & M. Eric Gershwin. 2004. Infection and Autoimmunity. Infection and Autoimmunity
537
547
.
Christopher Christophi, Mehrdad Nikfarjam, Vijayaragavan Muralidharan & Frank Dudley. (2003) Primary bile duct carcinoma in histocompatibility antigen-identical twins. Journal of Gastroenterology and Hepatology 18:4, pages 469-472.
Crossref
Crossref
D.C. Tong & M.M. Ferguson. (2002) Concurrent oral lichen planus and primary sclerosing cholangitis. British Journal of Dermatology 147:2, pages 356-358.
Crossref
Crossref
Erik Schrumpf & Kirsten Muri Boberg. (2002) Endoscopic treatment for primary sclerosing cholangitis?. Journal of Hepatology 36:2, pages 278-279.
Crossref
Crossref
T Orth, R Kellner, O Diekmann, J Faust, K-H Meyer Zum Büschenfelde & W-J Mayet. (1998) Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis. Clinical and Experimental Immunology 112:3, pages 507-515.
Crossref
Crossref
Cyriel Y. Ponsioen, Pieter C.F. Stokkers, Ann R. vd Horst, Guido N.J. Tytgat & Sander J.H. van Deventer. (2001) A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. European Journal of Internal Medicine 12:6, pages 518-521.
Crossref
Crossref
Sue Cullen & Roger Chapman. (2001) Aetiopathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 577-589.
Crossref
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2001) Natural history and prognostic models in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 563-575.
Crossref
Crossref
Thomas Orth, Markus Neurath, Peter Schirmacher, Peter R. Galle & Werner-Johannes Mayet. (2000) A novel rat model of chronic fibrosing cholangitis induced by local administration of a hapten reagent into the dilated bile duct is associated with increased TNF-α production and autoantibodies. Journal of Hepatology 33:6, pages 862-872.
Crossref
Crossref
S. Saarinen, O. Olerup & U. Broome. (2000) Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. The American Journal of Gastroenterology 95:11, pages 3195-3199.
Crossref
Crossref
Jayant A. Talwalkar, Nicholas F. LaRusso & Keith D. Lindor. (2000) Defining the relationship between autoimmune disease and primary sclerosing cholangitis. The American Journal of Gastroenterology 95:11, pages 3024-3026.
Crossref
Crossref
Vivek Raj & David R. Lichtenstein. (1999) HEPATOBILIARY MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 491-513.
Crossref
Crossref
A. Spurkland, S. Saarinen, K.M. Boberg, S. Mitchell, U. Broome, L. Caballeria, E. Ciusani, R. Chapman, G. Ercilla, O. Fausa, I. Knutsen, A. Pares, F. Rosina, O. Olerup, E. Thorsby & E. Schrumpf. (1999) HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:5, pages 459-469.
Crossref
Crossref
Jesús K. Yamamoto-Furusho, Carlos Cantú, Gilberto Vargas-Alarcón, Felipe Andrade, Joaquín Zúñiga, Joel Rodriguez, Ramón Boom & Julio Granados. (1998) Complotype SC30 Is Associated With Susceptibility to Develop Ulcerative Colitis in Mexicans. Journal of Clinical Gastroenterology 27:2, pages 178-179.
Crossref
Crossref
AKITAKA NONOMURA, NAOKO KONO, HIROSHI MINATO & YASUNI NAKANUMA. (2008) Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graft‐versus‐host disease in mice. Pathology International 48:6, pages 421-427.
Crossref
Crossref
James M McGill & Ann P Kwiatkowski. (1998) Cholestatic Liver Diseases in Adults. American Journal of Gastroenterology 93:5, pages 684-691.
Crossref
Crossref
Marion G. Peters. (1998) PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS, PRIMARY SCLEROSING CHOLANGITIS, AND AUTOIMMUNE CHOLANGIOPATHY. Clinics in Liver Disease 2:2, pages 235-247.
Crossref
Crossref
Cynthia M. Magro & A. Neil Crowson. (2008) A distinctive vesiculopustular eruption associated with hepatobiliary disease. International Journal of Dermatology 36:11, pages 837-844.
Crossref
Crossref